Transverse Tibial Bone Transport for Diabetic Foot Ulcers

This trial tests a new technique called transverse tibial bone transport to determine its effectiveness in healing diabetic foot ulcers unresponsive to standard care. It evaluates the technique's success in wound healing and limb preservation for individuals with limited treatment options. The trial includes two groups: one receives standard wound care, while the other receives standard care plus the new bone transport technique. Individuals with a diabetic foot ulcer lasting over 12 weeks, unhealed by regular treatment, might be suitable candidates.

As an unphased trial, this study presents a unique opportunity to explore an innovative treatment that could offer new hope for healing.

The trial does not specify if you need to stop taking your current medications. However, if you are taking corticosteroids at a dose higher than 10mg of prednisone daily for more than 2 weeks, you may not be eligible to participate.

Research has shown that transverse tibial bone transport (TTT) is generally well-tolerated by patients. In one study, 94% of ulcers healed, and only 10% of patients experienced complications, indicating the treatment's effectiveness with minimal issues. Another study found that TTT improved blood flow and reduced pain, promising signs for its safety and effectiveness.

Transverse Tibial Bone Transport is unique because it offers a novel approach to treating diabetic foot ulcers by promoting the body's natural ability to regenerate tissue. Unlike standard wound care, which typically involves cleaning, dressing, and sometimes antibiotics, this technique uses a mechanical method to encourage new bone and tissue growth in the affected area. Researchers are excited about this treatment because it has the potential to significantly accelerate healing and reduce the risk of complications, such as infections or amputations, that often accompany chronic diabetic foot ulcers. This innovative method could pave the way for more effective and faster recovery options for patients suffering from this debilitating condition.

Research has shown that transverse tibial bone transport may help treat diabetic foot ulcers. In this trial, some participants will receive standard wound care plus transverse tibial bone transport, while others will receive standard wound care alone. Studies have found that up to 96% of these ulcers healed within two years with transverse tibial bone transport. Additionally, up to 98% of patients retained their limbs. This treatment improves blood flow and skin temperature, which are crucial for healing. Most patients experience less pain and better foot function after the procedure. Overall, this technique could be a valuable option for those with limited choices for managing severe diabetic foot ulcers.²³⁵⁶⁷